Pair Name | All-trans retinoic acid, Salinomycin | ||
Phytochemical Name | All-trans retinoic acid (PubChem CID: 444795 ) | ||
Anticancer drug Name | Salinomycin (PubChem CID: 3085092 ) | ||
Structure of Phytochemical |
Download
2D
MOL
3D
MOL
|
||
Structure of Anticancer Drug |
Download
2D
MOL
3D
MOL
|
Pair Name | All-trans retinoic acid, Salinomycin | |||
Disease Info | [ICD-11: 2A60.Z] | Acute myeloid leukemia | Investigative | |
Biological Phenomena | Induction-->Apoptosis | |||
Gene Regulation | Down-regulation | Expression | BIRC5 | hsa332 |
Down-regulation | Expression | CASP3 | hsa836 | |
Down-regulation | Expression | CASP7 | hsa840 | |
Down-regulation | Expression | CCND1 | hsa595 | |
Down-regulation | Expression | CDC25A | hsa993 | |
Down-regulation | Expression | CTNNB1 | hsa1499 | |
Down-regulation | Phosphorylation | GSK3B | hsa2932 | |
Down-regulation | Expression | LRP6 | hsa4040 | |
Down-regulation | Expression | MYC | hsa4609 | |
Result | S+RA induced differentiation by β-catenin-inhibition-mediated up-regulation of C/EBPs and PU.1 and suppression of c-Myc. S+RA triggered apoptosis through β-catenin-inhibition-regulated ΔΨm collapse and caspase-3/7 activation. Taken together, our findings may provide novel therapeutic strategies for AML patients by targeting the WNT/β-catenin pathway. |
No. | Title | Href |
---|---|---|
1 | Combined Application of Salinomycin and ATRA Induces Apoptosis and Differentiation of Acute Myeloid Leukemia Cells by Inhibiting WNT/β-Catenin Pathway. Anticancer Agents Med Chem. 2023;23(9):1074-1084. doi: 10.2174/1871520623666230110121629. | Click |